Vice President for Device & Delivery Solutions Quality area in R&D Quality
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Are you passionate about quality and new technologies? Then this could be the opportunity for you! We are seeking an ambitious VP to lead the Device & Delivery Solutions (DDS) Quality area in R&D Quality. About the position The VP is responsible for setting the strategic direction, and for defining, organising, and leading the quality activities covering Devices and Delivery Solutions (DDS), an SVP area within the Development organisation, as well as device related quality activities within our Cell Therapy area. The DDS Quality area has approx. 30 employees, the majority located in Denmark, but with representation in both Seattle, Boston and Fremont in the US. The area currently consists of two departments, and we are planning significant expansions during 2023-2024. We are a global organisation with many different nationalities, so good intercultural collaboration skills are key. The DDS SVP area is working to execute on the recently updated strategic priorities within devices and delivery solutions, covering new device platforms, Software as Medical Device (SaMD), as well as partnerships. Thus, we have a strong focus on adapting processes and the way we work, and you will be playing a key role in driving new strategic- and improvement initiatives. Through this, you will have excellent opportunities to create impact across the R&D value chain by leading and developing an industry-leading QA function. The job holds ample opportunities for personal development and the interaction with diverse stakeholders across Development and Quality provides a unique learning opportunity. You will report to the CVP, R&D Quality and be an active member of the R&D Quality leadership team as well as the DDS leadership team. Qualifications You have a relevant educational background, eg a Master’s Degree in natural sciences or engineering and experience within drug and device development as well as: Substantial business understanding and experience from positions within the R&D value chain Demonstrated ability to drive the establishment of lean and fit for purpose process landscapes in regulated environments – prior QA leadership experience from a MedTech environment is a strong plus Strong focus on continuous improvements to enable a highly productive DDS organisation Proven experience with change management People management Further, we expect you to be interested in applying new technologies and have great interest in digitalisation. We are looking for a candidate who can set direction, and who can build and lead a strong team able to impact our development portfolio as QA partners and QA responsible. With new external requirements coming forward there is a need to address these proactively and prepare the organisation from QA and into the line perspective. We expect that you are curious to learn, change prepared and have great communication skills to ensure smooth collaboration with key stakeholders across organisational borders. About the area R&D Quality is a growing, dynamic area with responsibility for assuring quality across both the Research and Early Development and Development organisation. We are approximately 125 dedicated colleagues divided into 4 different areas, R&D Quality Operations, Clinical Quality, GS, RA & IT Quality and DDS Quality. You will be part of a high performing culture with focus on quality, patient safety, cross-functional collaboration, and personal development. We are passionate about reaching our ambitious goals as a team, we are curious and courageous, always striving for simplicity and we believe in developing people through trust and empowerment. Contact
To learn more about the position, you are welcome to contact Hanne Cloetta Lang at [email protected] or mobile +4530791989 in week 29 - 31 or Kristina Kleis Lock +4530756980 in week 26-27. Mails send in week 28 will be replied in week 29. Deadline for applications
4 August 2023 We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
To learn more about the position, you are welcome to contact Hanne Cloetta Lang at [email protected] or mobile +4530791989 in week 29 - 31 or Kristina Kleis Lock +4530756980 in week 26-27. Mails send in week 28 will be replied in week 29. Deadline for applications
4 August 2023 We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 16.6.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Øvrige
- Søborg
Lignende jobs
-
Øvrige i København Ø
Fri kontaktSenior Associates og Managere til Transaction Advisory Service i København. Vi mærker en stigende efterspørgsel efter rådgivning i forbindelse med køb og salg af virksomheder, herunder finansiel due diligence. Derfor søger vi Senior Associates og Managere til vores TAS team på Østerbro.Få mere info- Øvrige
- København Ø
-
Øvrige i København K
Fri kontaktAssociate til IT Risk Assurance. Vi vækster i Grant Thorntons IT Risk Assurance & Advisory Services, og søger derfor en nyuddannet kollega. I afdelingen beskæftiger vi os med IT-revision, afgivelse af IT-erklæringer (ISAE 3402, ISAE 3000 mv.Få mere info- Øvrige
- København K
-
Øvrige (studiejob) i København V
Fri kontaktVil du arbejde med grøn omstilling af transporten og analyser af mobilitet? Vil du lære mere om politisk interessevaretagelse? Så har du mulighed for at blive en del af et stærkt team i Danmarks største erhvervsorganisation for transport.Få mere info- Øvrige
- København V
-
Øvrige i København V
Fri kontaktVil du være med til at skabe forståelse for og bedre rammer for en central sektor i samfundsudviklingen og den grønne omstilling, så er arbejdet som konsulent i DI Ejendom måske noget for dig.Få mere info- Øvrige
- København V
Statistik over udbudte jobs som øvrige i Søborg
Herunder ser du udviklingen i udbudte øvrige i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
Se flere statistikker her:
Statistik over udbudte øvrige over tid
| Dato | Alle jobs som øvrige |
|---|---|
| 15. maj 2024 | 74 |
| 14. maj 2024 | 72 |
| 13. maj 2024 | 66 |
| 12. maj 2024 | 72 |
| 11. maj 2024 | 72 |
| 10. maj 2024 | 70 |
| 9. maj 2024 | 73 |
| 8. maj 2024 | 71 |
| 7. maj 2024 | 68 |
| 6. maj 2024 | 70 |
| 5. maj 2024 | 70 |
| 4. maj 2024 | 72 |
| 3. maj 2024 | 75 |
| 2. maj 2024 | 68 |
| 1. maj 2024 | 77 |
| 30. april 2024 | 82 |
| 29. april 2024 | 81 |
| 28. april 2024 | 79 |
| 27. april 2024 | 78 |
| 26. april 2024 | 80 |
| 25. april 2024 | 78 |
| 24. april 2024 | 78 |
| 23. april 2024 | 82 |
| 22. april 2024 | 84 |
| 21. april 2024 | 85 |
| 20. april 2024 | 87 |
| 19. april 2024 | 86 |
| 18. april 2024 | 81 |
| 17. april 2024 | 80 |
| 16. april 2024 | 80 |
| 15. april 2024 | 84 |